申请人:ABBOTT LABORATORIES
公开号:EP0499987A1
公开(公告)日:1992-08-26
Indole compounds substituted at the 1- or 3-position by a (pyrid-3-yl)thiazolid-4-yl)alkyl-, (pyrid-3-yl)thiazolid-4-oyl)-, (pyrid-3-yl)dithiolan-4-yl)alkyl- or (pyrid-3-yl)dithiolan-4-oyl)- group are potent inhibitors of PAF and are useful in the treatment of PAF-related disorders including septic shock, respiratory distress syndrome, acute inflammation, delayed cellular immunity, parturtition, fetal lung maturation, and cellular differentiation.
在 1 位或 3 位被(吡啶-3-基)噻唑-4-基)烷基、(吡啶-3-基)噻唑-4-酰基、(吡啶-3-基)二硫环戊-4-基)烷基或(吡啶-3-基)二硫环戊-4-酰基取代的吲哚化合物是 PAF 的强效抑制剂,可用于治疗与 PAF 有关的疾病,包括脓毒性休克、呼吸窘迫综合征、急性炎症、细胞免疫延迟、妊娠、胎儿肺成熟和细胞分化、可用于治疗与 PAF 有关的疾病,包括脓毒性休克、呼吸窘迫综合征、急性炎症、细胞免疫延迟、部分喷射、胎儿肺成熟和细胞分化。